# Oxidative Stress Mediated by Macrophages Promotes Angiogenesis and Early Development of Endometriosis

**Authors:** Gene Chi Wai Man, Astrid Borchert, Tao Zhang, Sze Wan Hung, Hartmut Kühn, Chi Chiu Wang

PMC · DOI: 10.3390/antiox15020159 · Antioxidants · 2026-01-23

## TL;DR

Macrophage-driven oxidative stress promotes early endometriosis development through increased angiogenesis, suggesting anti-inflammatory and antioxidant therapies may be effective.

## Contribution

This study identifies the Alox15 pathway and HIF-1α signaling as key in macrophage-mediated oxidative stress and neovascularization in early endometriosis.

## Key findings

- Macrophage depletion reduces oxidative stress, lesion size, and neovascularization in endometriosis.
- Inactivation of Alox15 similarly reduces oxidative stress and lesion growth.
- HIF-1α inhibition confirms its role in neovascularization and lesion progression.

## Abstract

Endometriosis is a hormone-dependent gynecological disease manifested by cyclic pelvic pain and female infertility. Although many studies have shown that neoangiogenesis plays an essential role in the development of early endometriosis, the underlying pathophysiological mechanisms remain unclear. Recent evidence suggests that macrophages play an important role in the pathogenesis of endometriosis and that the hypoxia-inducible factor-1alpha (HIF-1α) may be involved, but when and how are largely unknown. Herein, we explore the role of macrophages in the early development of endometriosis using an in vivo subcutaneous implantation murine model. Upon depletion of macrophages, the subcutaneous injection of syngeneic endometrial material resulted in significant reduction in oxidative stress, endometriotic lesion size, and neovascularization. Likewise, inactivation of the lipid peroxidative gene Alox15 induced similar reduction in oxidative stress, lesion growth, and angiogenesis. Since HIF-1α is an important trigger of neoangiogenesis, we further administered a HIF-1α-specific inhibitor (PX-478) to our endometriotic model and further confirmed the same effects on the lesions. Taken together, these data suggest that an intact Alox15 pathway and HIF-1α signaling may play important roles in the macrophage-mediated oxidative stress and neovascularization of endometriosis in the early stages, suggesting anti-inflammation and antioxidation as potential therapeutic targets for the development of endometriosis.

## Linked entities

- **Genes:** ALOX15 (arachidonate 15-lipoxygenase) [NCBI Gene 246], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091]
- **Chemicals:** PX-478 (PubChem CID 11234794)
- **Diseases:** endometriosis (MONDO:0005133)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Alox15 (arachidonate 15-lipoxygenase) [NCBI Gene 11687] {aka 12-LO, 12/15-LO, 15-LOX, Alox12l, L-12LO}, LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, Cd34 (CD34 antigen) [NCBI Gene 12490], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, ALOX15 (arachidonate 15-lipoxygenase) [NCBI Gene 246] {aka 12-LOX, 15-LOX, 15-LOX-1, LOG15}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Dcn (decorin) [NCBI Gene 13179] {aka DC, DSPG2, PG40, PGII, PGS2, SLRR1B}, Myd88 (myeloid differentiation primary response gene 88) [NCBI Gene 17874], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, CD34 (CD34 molecule) [NCBI Gene 947], Ubc (ubiquitin C) [NCBI Gene 22190] {aka 2700054O04Rik, Rps27a, TI-225, Uba52, Ubb}, Atm (ataxia telangiectasia mutated) [NCBI Gene 11920] {aka C030026E19Rik}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}
- **Diseases:** necrosis (MESH:D009336), Endometrial lesions (MESH:D014591), heart failure (MESH:D006333), gynecological disease (MESH:D005831), myocardial infarction (MESH:D009203), macrophage deficiency (MESH:D055501), thrombosis (MESH:D013927), metastasis (MESH:D009362), hypertension (MESH:D006973), ectopic endometrium (MESH:D016889), menstrual disorder (MESH:D004412), pelvic pain (MESH:D017699), proteinuria (MESH:D011507), hypoxia (MESH:D000860), autoimmune diseases (MESH:D001327), Endometriotic Lesions (MESH:D009059), hemorrhage (MESH:D006470), hypoxic (MESH:D002534), stroke (MESH:D020521), diabetes (MESH:D003920), cancer (MESH:D009369), neurodegenerative disorders (MESH:D019636), injury to (MESH:D014947), circulatory shock (MESH:D012769), chronic inflammation (MESH:D007249), female infertility (MESH:D007247), Endometriosis (MESH:D004715)
- **Chemicals:** eosin (MESH:D004801), PBS (MESH:D007854), RNS (MESH:D011886), ROS (MESH:D017382), luminol (MESH:D008165), luciferin (MESH:D000090562), lipid (MESH:D008055), 2-OHE2 (MESH:C001390), Estradiol benzoate (MESH:C074283), dUTP (MESH:C027078), 8-Isoprostanes (MESH:C075750), indomethacin (MESH:D007213), 2-methylestradiol (MESH:C037233), ICG (MESH:D007208), DAB (-), hydrogen peroxide (MESH:D006861), 15-hydroperoxy arachidonic acid (MESH:C025086), polyunsaturated fatty acids (MESH:D005231), hematoxylin (MESH:D006416), HCL (MESH:D006851), FITC-Dextran (MESH:C015219), H2O. (MESH:D014867), phospholipid (MESH:D010743), 8-amino-5-chloro-7-phenyl-pyrido[3,4-d]pyridazine-1,4(2H,3H)dione (MESH:C081614), phenol (MESH:D019800), isoflurane (MESH:D007530), 17beta-estradiol (MESH:D004958), EDTA (MESH:D004492), xylazine (MESH:D014991), PX 478 (MESH:C492908), nylon (MESH:D009757), paraffin (MESH:D010232), phosphate (MESH:D010710), oxygen (MESH:D010100)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** D104N
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), Hep3B — Homo sapiens (Human), Childhood hepatocellular carcinoma, Cancer cell line (CVCL_0326)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937962/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937962/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937962/full.md

---
Source: https://tomesphere.com/paper/PMC12937962